HIV infection in the setting of PrEP: Development of antiretroviral resistance and breakthrough infection. Report of two cases in real-life

Enferm Infecc Microbiol Clin (Engl Ed). 2022 May;40(5):280-281. doi: 10.1016/j.eimce.2021.11.009.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Anti-Retroviral Agents / therapeutic use
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans

Substances

  • Anti-HIV Agents
  • Anti-Retroviral Agents